TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS National Framework for Transition products commencing 1 May 2024

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Framework for Transition products commencing 1 May 2024". Published status: complete. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
66.2Bids / Report
11.9% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 515 active published awards; 512 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published24 Apr 2024, 10:47 BST
Last source update24 Apr 2024, 10:47 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-043aa8
What is being bought
Project title: NHS National Framework for Transition products commencing 1 May 2024<br/>Offer reference number: CM/TNS/05/2024<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/TNS/05/2024/01<br/>Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months)<br/>Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months)<br/><br/>CM/TNS/05/2024/02<br/>Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
What changed
From the official release history
  1. tender value changed
    24 Apr 2024, 10:47 BST
  2. Status changed to complete
    24 Apr 2024, 10:47 BST
  3. Official notice release published
    24 Apr 2024, 10:47 BST
  4. Submission deadline changed to published date
    24 Apr 2024, 10:47 BST
  5. Published value updated to £179,392,000
    16 Feb 2024, 11:14 GMT
  6. Status changed to active
    16 Feb 2024, 11:14 GMT
  7. Official notice release published
    16 Feb 2024, 11:14 GMT
  8. Submission deadline changed to 18 Mar 2024, 13:00 GMT
    16 Feb 2024, 11:14 GMT
  9. Buyer information updated
    16 Feb 2024, 11:14 GMT
Lots and requirements (2)
Published by the contracting authority
  • Lot 1 · #1
    CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin
    cancelled
    Published valueNot published
    CM/TNS/05/2024/01<br/>Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months)<br/>Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months) <br/>Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months) Additional information: CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin<br/>Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months)<br/>Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    CM/TNS/05/2024/02 - Apixaban, Sapropterin
    cancelled
    Published valueNot published
    CM/TNS/05/2024/02<br/>Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months) <br/>Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months) Additional information: CM/TNS/05/2024/02 - Apixaban, Sapropterin<br/>Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    24 Apr 2024, 10:47 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  17. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  18. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  19. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  20. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  21. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  22. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  23. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  24. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  25. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  26. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  27. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  28. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
  29. Contract active
    Signed 18 Apr 2024, 00:00 BST · £1
Commercial outcome and competition
Awards
Kent Pharma Ltd
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Glenmark Pharmaceuticals Europe Limited
Not published · Not published · active
Mylan
Not published · Not published · active
Selective Supplies Ltd.
Not published · Not published · active
LogixX Pharma Ltd
Not published · Not published · active
Celix Pharma Ltd.
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Mylan
Not published · Not published · active
Sandoz Ltd
Not published · Not published · active
Immedica Pharma AB
Not published · Not published · active
Aspire Pharma Limited
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Contracts
Dimethyl fumarate, Teriflunomide, Trabectedin
£1 · signed 18 Apr 2024, 00:00 BST · active
Apixaban, Sapropterin
£1 · signed 18 Apr 2024, 00:00 BST · active
Apixaban, Sapropterin
£1 · signed 18 Apr 2024, 00:00 BST · active
Apixaban, Sapropterin
£1 · signed 18 Apr 2024, 00:00 BST · active
Apixaban, Sapropterin
£1 · signed 18 Apr 2024, 00:00 BST · active
Apixaban, Sapropterin
£1 · signed 18 Apr 2024, 00:00 BST · active
Dimethyl fumarate, Teriflunomide, Trabectedin
£1 · signed 18 Apr 2024, 00:00 BST · active
Dimethyl fumarate, Teriflunomide, Trabectedin
£1 · signed 18 Apr 2024, 00:00 BST · active
Dimethyl fumarate, Teriflunomide, Trabectedin
£1 · signed 18 Apr 2024, 00:00 BST · active
Dimethyl fumarate, Teriflunomide, Trabectedin
£1 · signed 18 Apr 2024, 00:00 BST · active
Dimethyl fumarate, Teriflunomide, Trabectedin
£1 · signed 18 Apr 2024, 00:00 BST · active
Dimethyl fumarate, Teriflunomide, Trabectedin
£1 · signed 18 Apr 2024, 00:00 BST · active
Dimethyl fumarate, Teriflunomide, Trabectedin
£1 · signed 18 Apr 2024, 00:00 BST · active
Apixaban, Sapropterin
£1 · signed 18 Apr 2024, 00:00 BST · active
Bid statistics
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
foreignBidsFromEU: 16 (lot 1)
foreignBidsFromEU: 16 (lot 1)
foreignBidsFromEU: 16 (lot 1)
foreignBidsFromEU: 16 (lot 1)
foreignBidsFromEU: 16 (lot 1)
foreignBidsFromEU: 16 (lot 1)
foreignBidsFromEU: 16 (lot 1)
foreignBidsFromEU: 16 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
smeBids: 9 (lot 1)
smeBids: 9 (lot 1)
smeBids: 9 (lot 1)
smeBids: 9 (lot 1)
smeBids: 9 (lot 1)
smeBids: 9 (lot 1)
smeBids: 9 (lot 1)
smeBids: 9 (lot 1)
bids: 9 (lot 2)
bids: 9 (lot 2)
bids: 9 (lot 2)
bids: 9 (lot 2)
bids: 9 (lot 2)
bids: 9 (lot 2)
electronicBids: 9 (lot 2)
electronicBids: 9 (lot 2)
electronicBids: 9 (lot 2)
electronicBids: 9 (lot 2)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-67205
View buyer profile

  • NHS England
    buyer
    centralPurchasingBody

    1st Floor, Quarry House, Quarry Hill, Leeds, UKE, LS2 7UE
    katie.noonan@nhs.net

  • Aspire Pharma Limited
    supplier

    06828501
    102 High Street,, Godalming, Surrey., UK, GU7 1DS

  • Celix Pharma Ltd.
    supplier

    12474195
    12 Constance Street, International House,, London, UK, E16 2DQ

  • Dr.Reddy's Laboratories (UK) Limited
    supplier

    1729064
    410, Cambridge Science Park Milton Rd, Milton,, Cambridge, UK, CB4 0PE

  • Glenmark Pharmaceuticals Europe Limited
    supplier

    50402060
    2-B Laxmi House, Draycott Avenue Kenton, Harrow,, Middlesex,, UK, HA3 0BU

  • Immedica Pharma AB
    supplier

    1147556
    Immedica Pharma, The Townhouse, 114-116 Fore Street,, Hertford, Herts,, UK, SG14 1AJ

  • Kent Pharma Ltd
    supplier

    11576098
    Kent Pharma UK Ltd, 2nd Floor, Connect 38, 1 Dover Place,, Ashford, Kent,, UK, TN23 1FB

  • LogixX Pharma Ltd
    supplier

    07209211
    LogixX Pharma Limited, Suite 117, Merlin House, Brunel Road, Theale,, Reading, UK, RG7 4AB

  • Mylan
    supplier

    09189103
    Building 4 Trident Place, Mosquito Way,, Hatfield,, UK, AL10 9UL

  • Sandoz Ltd
    supplier

    01547204
    Park View, Riverside Way, Watchmoor Park,, Camberley, Surrey., UK, GU15 3YL

  • Selective Supplies Ltd.
    supplier

    03794482
    Fifth Floor Watson House, 54-60 Baker Street,, London,, UK, W1U 7BU

  • Teva UK Limited
    supplier

    302461
    Ridings Point, Whistler Drive,, Castleford,, UK, WF10 5HX

  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL

  • Thornton and Ross Ltd
    supplier

    00185947
    Linthwaite Laboratories, Manchester Road, Linthwaite,, Huddersfield, UK, HD7 5QH
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published